Olli Vapalahti

InstitutionUniversity of Helsinki
AddressHelsinki
Finland
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 4 publications in May 2021
    All Publications
    Bar chart showing 288 publications over 27 distinct years, with a maximum of 25 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kreutzberger AJB, Sanyal A, Ojha R, Pyle JD, Vapalahti O, Balistreri G, Kirchhausen T. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease. J Virol. 2021 10 13; 95(21):e0097521. PMID: 34406858.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    2. Truong Nguyen PT, Plyusnin I, Sironen T, Vapalahti O, Kant R, Smura T. HAVoC, a bioinformatic pipeline for reference-based consensus assembly and lineage assignment for SARS-CoV-2 sequences. BMC Bioinformatics. 2021 Jul 17; 22(1):373. PMID: 34273961.
      Citations: 1     Fields:    Translation:Humans
    3. Cabrera LE, Pekkarinen PT, Alander M, Nowlan KHA, Nguyen NA, Jokiranta S, Kuivanen S, Patjas A, Mero S, Pakkanen SH, Heinonen S, Kantele A, Vapalahti O, Kekäläinen E, Strandin T. Characterization of low-density granulocytes in COVID-19. PLoS Pathog. 2021 07; 17(7):e1009721. PMID: 34228753.
      Citations: 3     Fields:    Translation:HumansCells
    4. Jalkanen P, Kolehmainen P, Häkkinen HK, Huttunen M, Tähtinen PA, Lundberg R, Maljanen S, Reinholm A, Tauriainen S, Pakkanen SH, Levonen I, Nousiainen A, Miller T, Välimaa H, Ivaska L, Pasternack A, Naves R, Ritvos O, Österlund P, Kuivanen S, Smura T, Hepojoki J, Vapalahti O, Lempainen J, Kakkola L, Kantele A, Julkunen I. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun. 2021 06 28; 12(1):3991. PMID: 34183681.
      Citations: 44     Fields:    Translation:HumansPHPublic Health
    5. Salmi H, Heinonen S, Hästbacka J, Lääperi M, Rautiainen P, Miettinen PJ, Vapalahti O, Hepojoki J, Knip M. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2022 02; 107(2):180-185. PMID: 34045208.
      Citations: 4     Fields:    
    6. Virtanen J, Uusitalo R, Korhonen EM, Aaltonen K, Smura T, Kuivanen S, Pakkanen SH, Mero S, Patjas A, Riekkinen M, Kantele A, Nurmi V, Hedman K, Hepojoki J, Sironen T, Huhtamo E, Vapalahti O. Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays. Viruses. 2021 05 26; 13(6). PMID: 34073577.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    7. Kortela E, Kirjavainen V, Ahava MJ, Jokiranta ST, But A, Lindahl A, Jääskeläinen AE, Jääskeläinen AJ, Järvinen A, Jokela P, Kallio-Kokko H, Loginov R, Mannonen L, Ruotsalainen E, Sironen T, Vapalahti O, Lappalainen M, Kreivi HR, Jarva H, Kurkela S, Kekäläinen E. Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients. PLoS One. 2021; 16(5):e0251661. PMID: 34019562.
      Citations: 5     Fields:    Translation:Humans
    8. Rusanen J, Kareinen L, Szirovicza L, Ugurlu H, Levanov L, Jääskeläinen A, Ahava M, Kurkela S, Saksela K, Hedman K, Vapalahti O, Hepojoki J. A Generic, Scalable, and Rapid Time-Resolved Förster Resonance Energy Transfer-Based Assay for Antigen Detection-SARS-CoV-2 as a Proof of Concept. mBio. 2021 05 18; 12(3). PMID: 34006662.
      Citations: 5     Fields:    Translation:HumansCells
    9. Jääskeläinen AE, Ahava MJ, Jokela P, Szirovicza L, Pohjala S, Vapalahti O, Lappalainen M, Hepojoki J, Kurkela S. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021 04; 137:104785. PMID: 33711694.
      Citations: 11     Fields:    Translation:Humans
    10. Lin JW, Tang C, Wei HC, Du B, Chen C, Wang M, Zhou Y, Yu MX, Cheng L, Kuivanen S, Ogando NS, Levanov L, Zhao Y, Li CL, Zhou R, Li Z, Zhang Y, Sun K, Wang C, Chen L, Xiao X, Zheng X, Chen SS, Zhou Z, Yang R, Zhang D, Xu M, Song J, Wang D, Li Y, Lei S, Zeng W, Yang Q, He P, Zhang Y, Zhou L, Cao L, Luo F, Liu H, Wang L, Ye F, Zhang M, Li M, Fan W, Li X, Li K, Ke B, Xu J, Yang H, He S, Pan M, Yan Y, Zha Y, Jiang L, Yu C, Liu Y, Xu Z, Li Q, Jiang Y, Sun J, Hong W, Wei H, Lu G, Vapalahti O, et al. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe. 2021 03 10; 29(3):489-502.e8. PMID: 33548198.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    11. Citations: 8     
    12. Rusanen J, Kareinen L, Levanov L, Mero S, Pakkanen SH, Kantele A, Amanat F, Krammer F, Hedman K, Vapalahti O, Hepojoki J. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2. Viruses. 2021 Jan 20; 13(2). PMID: 33498157.
      Citations: 3     Fields:    Translation:Humans
    13. Kantele A, Lääveri T, Kareinen L, Pakkanen SH, Blomgren K, Mero S, Patjas A, Virtanen J, Uusitalo R, Lappalainen M, Järvinen A, Kurkela S, Jääskeläinen AJ, Vapalahti O, Sironen T. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Travel Med Infect Dis. 2021 Jan-Feb; 39:101949. PMID: 33321195.
      Citations: 4     Fields:    Translation:Humans
    14. Plyusnin I, Kant R, Jääskeläinen AJ, Sironen T, Holm L, Vapalahti O, Smura T. Novel NGS pipeline for virus discovery from a wide spectrum of hosts and sample types. Virus Evol. 2020 Jul; 6(2):veaa091. PMID: 33408878.
      Citations: 7     
    15. Haljasmägi L, Salumets A, Rumm AP, Jürgenson M, Krassohhina E, Remm A, Sein H, Kareinen L, Vapalahti O, Sironen T, Peterson H, Milani L, Tamm A, Hayday A, Kisand K, Peterson P. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19. Sci Rep. 2020 11 25; 10(1):20533. PMID: 33239683.
      Citations: 17     Fields:    Translation:HumansCells
    16. Citations: 413     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    17. Thi Kha Tu N, Thi Thu Hong N, Thi Han Ny N, My Phuc T, Thi Thanh Tam P, Doorn HRV, Dang Trung Nghia H, Thao Huong D, An Han D, Thi Thu Ha L, Deng X, Thwaites G, Delwart E, Virtala AK, Vapalahti O, Baker S, Van Tan L. The Virome of Acute Respiratory Diseases in Individuals at Risk of Zoonotic Infections. Viruses. 2020 08 29; 12(9). PMID: 32872469.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    18. Kantonen J, Mahzabin S, Mäyränpää MI, Tynninen O, Paetau A, Andersson N, Sajantila A, Vapalahti O, Carpén O, Kekäläinen E, Kantele A, Myllykangas L. Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol. 2020 11; 30(6):1012-1016. PMID: 32762083.
      Citations: 47     Fields:    Translation:Humans
    19. Rodriguez L, Pekkarinen PT, Lakshmikanth T, Tan Z, Consiglio CR, Pou C, Chen Y, Mugabo CH, Nguyen NA, Nowlan K, Strandin T, Levanov L, Mikes J, Wang J, Kantele A, Hepojoki J, Vapalahti O, Heinonen S, Kekäläinen E, Brodin P. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19. Cell Rep Med. 2020 08 25; 1(5):100078. PMID: 32838342.
      Citations: 55     
    20. Jääskeläinen AJ, Jääskeläinen AJ, Kuivanen S, Kekäläinen E, Ahava MJ, Loginov R, Kallio-Kokko H, Vapalahti O, Jarva H, Kurkela S, Lappalainen M. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation. J Clin Virol. 2020 08; 129:104512. PMID: 32563180.
      Citations: 80     Fields:    Translation:HumansCellsPHPublic Health
    21. Citations: 616     Fields:    Translation:HumansCellsPHPublic Health
    22. Jääskeläinen AJ, Kekäläinen E, Kallio-Kokko H, Mannonen L, Kortela E, Vapalahti O, Kurkela S, Lappalainen M. Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples. Euro Surveill. 2020 05; 25(18). PMID: 32400364.
      Citations: 48     Fields:    Translation:HumansCellsPHPublic Health
    23. Haveri A, Smura T, Kuivanen S, Österlund P, Hepojoki J, Ikonen N, Pitkäpaasi M, Blomqvist S, Rönkkö E, Kantele A, Strandin T, Kallio-Kokko H, Mannonen L, Lappalainen M, Broas M, Jiang M, Siira L, Salminen M, Puumalainen T, Sane J, Melin M, Vapalahti O, Savolainen-Kopra C. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020. Euro Surveill. 2020 03; 25(11). PMID: 32209163.
      Citations: 102     Fields:    Translation:HumansCellsPHPublic Health
    24. Kivistö I, Tidenberg EM, Lilley T, Suominen K, Forbes KM, Vapalahti O, Huovilainen A, Sironen T. First Report of Coronaviruses in Northern European Bats. Vector Borne Zoonotic Dis. 2020 02; 20(2):155-158. PMID: 31503522.
      Citations: 6     Fields:    Translation:AnimalsCells
    25. Hepojoki S, Lindh E, Vapalahti O, Huovilainen A. Prevalence and genetic diversity of coronaviruses in wild birds, Finland. Infect Ecol Epidemiol. 2017; 7(1):1408360. PMID: 30788065.
      Citations: 8     
    Vapalahti's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (392)
    Explore
    _
    Co-Authors (342)
    Explore
    _
    Similar People (60)
    Explore
    _